Cardlytics stock: buy or sell?
May 22nd, 2020
Cardlytics, Inc. operates purchase data intelligence platforms in the United States and the United Kingdom. The company operates through two segments, Cardlytics Direct and Other Platform Solutions.
Should I buy Cardlytics stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Having a trading plan helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Cardlytics stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Cardlytics stock a buy?
Financial institutions and banks publish stock ratings everyday.Unfortunately, we couldn't find any rating for CDLX stock for the last month.
Cardlytics stock analysis
Cardlytics ended yesterday at $70.74 and jumped a very good 2.91%.
Cardlytics closed yesterday at $70.74 and jumped a very good 2.91%. On May 15th CDLX price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. From a daily perspective, CDLX is in a short term uptrend after plotting its last bottom ($45.63, on May/14) higher than the previous bottom, and its last top ($72.83, on Wednesday) also over the previous top. Now trading in between its last bottom and last top CDLX might consolidate in a plain range, waiting to break out over $72.83 or down under $45.63. On February, CDLX hit a new all time high, pushing higher than on February tops. Check different trading setups that use ATHs as triggers.
Shares of Cardlytics ended this week at $70.74 and climbed an outstanding 28.18%. Late April CDLX plummed a bloodcurdling -9.63% in just one week. This week was the fourth green week in a row.
CDLX marked an uptrend of rising tops and rising bottoms. Since its last top by mid February at $107.50, price slid and bounced up back from $27.33. Breaking down under $27.33 would cancel the current uptrend and it might test lower supports. Note that $107.50 might act as a resistance line. Since price and SMA40w lines crossed up last week, CDLX climbed $20.08 (39.64%). Not so far away is the last all-time high Cardlytics marked by mid February, but since then it dropped a 34.20%.
Cardlytics stock price history
Cardlytics stock went public on February 9th, 2018 with a price of $12.101. Since then, CDLX stock surged a 484.60%, with a yearly average of 242.30%. If you had invested right after CDLX's IPO a $1,000 in Cardlytics stock in 2018, it would worth $4,846.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Cardlytics stock historical price chart
CDLX stock reached all-time highs on February with a price of $107.50.
Cardlytics stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we have not detected any price forecast for Cardlytics stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, Cardlytics reported its latest financial data, posting a great gain for the Earnings per Share (EPS) ratio. Analyst were expecting $-0.43 per share, but Cardlytics posted $-0.51.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual revenues report draw an outstanding growth of 15.59% to $150.68 M dollars. When comparing 2018 vs 2017, in contrary, profit margin (that is, the net income divided by revenues) plummed a -20.13% to -35.20%.
|2015||$78 M||-||$-40.63 M-52.3%||-|
|2016||$113 M||45.32%||$-75.70 M-67.1%||86.33%|
|2017||$130 M||15.55%||$-19.64 M-15.1%||-74.05%|
|2018||$151 M||15.59%||$-53.04 M-35.2%||170.06%|
Quarterly financial resultsCardlytics posted $47.82 M in sales for 2018-Q4, a 38.28% up compared to previous quarter. Reported quarter income marked $-11.57 million with a profit margin of -24.19%. Profit margin stayed constant a 0.01% compared to previous quarter when profit margin was -24.20%. When comparing sales to same quarter last year, Cardlytics sales marked an amazing gain and skyrocketed a 21.78%.
|2017-Q1||$27 M||-||$-12.46 M-46.4%||-|
|2017-Q2||$33 M||22.06%||$-0.65 M-2.0%||-94.80%|
|2017-Q3||$31 M||-4.28%||$-2.47 M-7.9%||281.79%|
|2017-Q4||$39 M||25.03%||$-4.06 M-10.3%||63.95%|
|2018-Q1||$33 M||-16.69%||$-20.06 M-61.3%||394.45%|
|2018-Q2||$36 M||8.73%||$-13.05 M-36.7%||-34.91%|
|2018-Q3||$35 M||-2.78%||$-8.37 M-24.2%||-35.89%|
|2018-Q4||$48 M||38.28%||$-11.57 M-24.2%||38.22%|
Cardlytics ownershipChecking Cardlytics ownership structure gives valuable information about the company and its governance (insider ownership) or the amount of investors that are on the short side.
Cardlytics shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 9.08% of all shares.
Bearish positions for CDLX stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$1.9 B|
|Total shares||27.0 M|
|Float shares||18.4 M|
|- Institutional holdings (%)||84.6%|
|- Insider holdings (%)||9.1%|
|Shares in short selling||0.0%|
|Friday, May 22nd, 2020|
|Day range||$67.10 - $70.97|
|Average true range||$6.41|
|50d mov avg||$44.64|
|100d mov avg||$61.95|
|200d mov avg||$52.73|
Cardlytics performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Cardlytics, the comparison is made against .